The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
the use of metformin in china is between 60 and 70 and you see the ratio of the people who are hospitalized was the opposite so i'm thinking less people on metformin showed up in the hospital and probably the mortality had to do more with the inflammatory with a cytokine storm or with their ability to handle severe disease than the immunization
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.